Mesoblast
MESO
$6.15
Share price
-1.13%
Change (1 day)
83.04%
Change (1 year)
Categories
Operating Margin for Mesoblast (MESO)
Operating Margin as of April 2024 (TTM): -1,101.46%
According to Mesoblast 's latest financial reports and stock price the company's current Operating Margin is -1,101.46%. At the end of 2022 the company had an Operating Margin of -896.93%.
Operating Margin history for Mesoblast from 2015 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -896.93% | -33.07% |
| 2021 | -1,340.19% | 385.02% |
| 2020 | -276.32% | -55.22% |
| 2019 | -617.10% | 58.77% |
| 2018 | -388.67% | -89.61% |
| 2017 | -3,740.26% | 1652.24% |
| 2016 | -213.46% | -57.53% |
| 2015 | -502.64% | 61.31% |
| 2014 | -311.60% | 49.3% |
| 2013 | -208.71% | 63.97% |
| 2012 | -127.28% | -266.85% |
| 2011 | 76.28% | -100.03% |
| 2010 | -268,743.55% | 19384.17% |
| 2009 | -1,379.29% | 24.71% |
| 2008 | -1,105.99% | 112.8% |
| 2007 | -519.74% | 76.73% |
| 2006 | -294.09% | 0.58% |
| 2005 | -292.39% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -234,760.00% | 21,213.53% | Bahamas |
 NRC Health
NRC | 32.86% | -102.98% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.